Semaglutide in people with obesity boosts wellbeing
Nordisk today announced new outcomes from the STEP stage 3a medical trial program, demonstrating likely benefits beyond weight reduction for individuals with obesity receiving treatment… Read More »Semaglutide in people with obesity boosts wellbeing